Cranial Perforator Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Age Group (Adult, Pediatric), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2023 - 2030

Cranial Perforator Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Age Group (Adult, Pediatric), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2023 - 2030


Cranial Perforator Market Growth & Trends


The global cranial perforator market size is anticipated to reach USD 163.7 million by 2030, registering a CAGR of 5.46% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by the rising adult population, technological advancements, and increasing incidence of neurological conditions, including stroke, brain aneurysm, & cerebral artery stenosis. As per the World Stroke Organization (WSO), it was estimated that by 2022, there will be more than 12.2 million new stroke cases annually. In addition, one out of every four adults above the age of 25 years will experience a stroke at some point in their life.

Moreover, major players invest in R&D activities to develop innovative devices that meet the specific needs of neurosurgeons and patients. They focus on improving the design, materials, and functionality of these instruments to enhance surgical outcomes and patient safety. Furthermore, prominent players collaborate with hospitals, research institutions, and other medical device companies to advance the field of neurosurgery and develop new technologies related to cranial perforators. Thus, due to such factors, the global market is expected to grow significantly in the near future.

Cranial Perforator Market Report Highlights

  • In 2022, the disposable type segment dominated the market with a market share of 89.8% due to their high demand as they eliminate the need for repeated sterilization and ensure a sterile, single-use instrument for each patient, reducing the risk of cross-contamination and infections as compared to reusable devices
  • The adult age group segment dominated the market in 2022 with a market share of 52.6% due to the high prevalence of neurological disorders in the adult population and an increased focus on advanced healthcare solutions for adults
  • The hospitals end-use segment held the largest share of 60.4% in 2022. The increasing patient population, along with the introduction of technologically advanced products and favorable reimbursement policies, is driving the demand for hospital-based treatments worldwide
  • North America led the market with the maximum revenue share of 38.7% in 2022. Rising demand for minimally invasive surgeries and supportive government initiatives for improving healthcare infrastructures dive the region’s growth
  • In addition, technological advancement and innovation of new non-invasive techniques will create lucrative growth opportunities for the regional market
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Age Group
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Age Group Outlook
2.2.3. End-use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Cranial Perforators Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Industry Value Chain Analysis
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of neurological disorders
3.3.1.2. Rising demand for minimally invasive surgical procedures
3.3.1.3. Technological advancements
3.3.2. Market restraint analysis
3.3.2.1. Complications associated with cranial perforators
3.3.2.2. Lack of skilled professionals
3.3.3. Market opportunity analysis
3.3.3.1. Improvement in healthcare infrastructure in developing economies
3.4. Cranial Perforators Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Cranial Perforators Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Reusable cranial perforators
4.1.2. Disposable cranial perforators
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Cranial Perforators Market by Type Outlook
4.5. Market Type & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Reusable cranial perforators
4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
4.5.2. Disposable cranial perforators
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Cranial Perforators: Age Group Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Adult
5.1.2. Pediatric
5.1.3. Adolescent
5.2. Age Group Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Cranial Perforators Market by Age Group Outlook
5.5. Market Age Group & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Adult
5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.1.2. Pediatric
5.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.1.3. Adolescent
5.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 6. Cranial Perforators: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Others
6.2. End-u se Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Cranial Perforators Market by End-use Outlook
6.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
6.5.2. Ambulatory surgical centers
6.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
6.5.3. Others
6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 7. Cranial Perforators Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 - 2030
7.7.2. Germany
7.7.2.1. Key country dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 - 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
7.7.5. Spain
7.7.5.1. Key country dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 - 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 - 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive Scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive Scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. ACRA-CUT Inc
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. adeor medical AG
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Cranial Cut
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Integra LifeSciences (CODMAN)
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Nouvag AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. VITALYS SURGICAL
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.8. Micromar Ind. e Com. LTDA
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Evonos GmbH & Co. KG
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Surtex Instruments Limited
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Shanghai LZQ Precision Tool
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings